Home Newsletters Hematopoiesis News Identification of Therapeutic Targets of the Hijacked Super-Enhancer Complex in EVI1-Rearranged Leukemia

Identification of Therapeutic Targets of the Hijacked Super-Enhancer Complex in EVI1-Rearranged Leukemia

0
The authors unraveled key components of G2DHE-bound transcription factors involved in the deregulation of EVI1.
[Leukemia]
6445212 {6445212:6UY5UGGE} apa 50 1 161734 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-c83d3af68e206895ec89f7d4a8c9e7e0%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%226UY5UGGE%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kiehlmeier%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKiehlmeier%2C%20S.%2C%20Rafiee%2C%20M.-R.%2C%20Bakr%2C%20A.%2C%20Mika%2C%20J.%2C%20Kruse%2C%20S.%2C%20M%26%23xFC%3Bller%2C%20J.%2C%20Schweiggert%2C%20S.%2C%20Herrmann%2C%20C.%2C%20Sigismondo%2C%20G.%2C%20Schmezer%2C%20P.%2C%20Krijgsveld%2C%20J.%2C%20%26amp%3B%20Gr%26%23xF6%3Bschel%2C%20S.%20%282021%29.%20Identification%20of%20therapeutic%20targets%20of%20the%20hijacked%20super-enhancer%20complex%20in%20EVI1%20-rearranged%20leukemia.%20%3Ci%3ELeukemia%3C%5C%2Fi%3E%2C%201%26%23x2013%3B12.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41375-021-01235-z%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41375-021-01235-z%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D6UY5UGGE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Identification%20of%20therapeutic%20targets%20of%20the%20hijacked%20super-enhancer%20complex%20in%20EVI1%20-rearranged%20leukemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Kiehlmeier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahmoud-Reza%22%2C%22lastName%22%3A%22Rafiee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Bakr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jagoda%22%2C%22lastName%22%3A%22Mika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Kruse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Schweiggert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%22%2C%22lastName%22%3A%22Herrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gianluca%22%2C%22lastName%22%3A%22Sigismondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Schmezer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeroen%22%2C%22lastName%22%3A%22Krijgsveld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%5D%2C%22abstractNote%22%3A%22Deregulation%20of%20the%20EVI1%20proto-oncogene%20by%20the%20GATA2%20distal%20hematopoietic%20enhancer%20%28G2DHE%29%20is%20a%20key%20event%20in%20high-risk%20acute%20myeloid%20leukemia%20carrying%203q21q26%20aberrations%20%283q-AML%29.%20Upon%20chromosomal%20rearrangement%2C%20G2DHE%20acquires%20characteristics%20of%20a%20super-enhancer%20and%20causes%20overexpression%20of%20EVI1%20at%203q26.2.%20However%2C%20the%20transcription%20factor%20%28TF%29%20complex%20of%20G2DHE%20remains%20poorly%20characterized.%20The%20aim%20of%20this%20study%20was%20to%20unravel%20key%20components%20of%20G2DHE-bound%20TFs%20involved%20in%20the%20deregulation%20of%20EVI1.%20We%20have%20identified%20several%20CEBPA%20and%20RUNX1%20binding%20sites%20to%20be%20enriched%20and%20critical%20for%20G2DHE%20function%20in%203q-AML%20cells.%20Using%20ChIP-SICAP%20%28ChIP%20followed%20by%20selective%20isolation%20of%20chromatin-associated%20proteins%29%2C%20a%20panel%20of%20chromatin%20interactors%20of%20RUNX1%20and%20CEBPA%20were%20detected%20in%203q-AML%2C%20including%20PARP1%20and%20IKZF1.%20PARP1%20inhibition%20%28PARPi%29%20caused%20a%20reduction%20of%20EVI1%20expression%20and%20a%20decrease%20in%20EVI1%5Cu2013G2DHE%20interaction%20frequency%2C%20highlighting%20the%20involvement%20of%20PARP1%20in%20oncogenic%20super-enhancer%20formation.%20Furthermore%2C%203q-AML%20cells%20were%20highly%20sensitive%20to%20PARPi%20and%20displayed%20morphological%20changes%20with%20higher%20rates%20of%20differentiation%20and%20apoptosis%20as%20well%20as%20depletion%20of%20CD34%5Cu2009%2B%5Cu2009cells.%20In%20summary%2C%20integrative%20analysis%20of%20the%203q-AML%20super-enhancer%20complex%20identified%20CEBPA%20and%20RUNX1%20associated%20proteins%20and%20nominated%20PARP1%20as%20a%20potential%20new%20therapeutic%20target%20in%20EVI1%5Cu2009%2B%5Cu20093q-AML.%22%2C%22date%22%3A%222021-04-28%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41375-021-01235-z%22%2C%22ISSN%22%3A%221476-5551%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41375-021-01235-z%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-29T16%3A29%3A31Z%22%7D%7D%5D%7D
Kiehlmeier, S., Rafiee, M.-R., Bakr, A., Mika, J., Kruse, S., Müller, J., Schweiggert, S., Herrmann, C., Sigismondo, G., Schmezer, P., Krijgsveld, J., & Gröschel, S. (2021). Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1 -rearranged leukemia. Leukemia, 1–12. https://doi.org/10.1038/s41375-021-01235-z Cite
Full Article
Exit mobile version